Bio Medica Laboratories Financials
NSE: BMLL
₹148.20
As on 16-Nov-2026IST
Market cap
₹186 Cr
Revenue (TTM)
₹43 Cr
P/E Ratio
15.8
P/B Ratio
6.2
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
43.09
|
38.32
|
--
|
--
|
--
|
--
|
|||||
|
Total Income
|
43.11
|
38.33
|
--
|
--
|
--
|
--
|
|||||
|
Total Expenditure
|
23.11
|
22.82
|
--
|
--
|
--
|
--
|
|||||
|
EBITDA
|
19.98
|
15.50
|
--
|
--
|
--
|
--
|
|||||
|
Depreciation
|
1.16
|
1.01
|
--
|
--
|
--
|
--
|
|||||
|
EBIT
|
18.81
|
14.49
|
--
|
--
|
--
|
--
|
|||||
|
Interest
|
2.58
|
1.35
|
--
|
--
|
--
|
--
|
|||||
|
Other Income
|
0.02
|
0.01
|
--
|
--
|
--
|
--
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
16.25
|
13.14
|
--
|
--
|
--
|
--
|
|||||
|
Provision for Tax
|
4.37
|
3.44
|
--
|
--
|
--
|
--
|
|||||
|
Profit after Tax
|
11.89
|
9.70
|
--
|
--
|
--
|
--
|
|||||
|
Minority Interest
|
-0.11
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
11.78
|
9.70
|
--
|
--
|
--
|
--
|
Liabilities (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
26.51
|
14.73
|
--
|
--
|
--
|
--
|
|||||
|
Minority Interest
|
-6.17
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
33.45
|
10.51
|
--
|
--
|
--
|
--
|
|||||
|
Current Liabilities
|
19.18
|
13.26
|
--
|
--
|
--
|
--
|
|||||
|
Total Liabilities
|
73.31
|
38.70
|
--
|
--
|
--
|
--
|
Assets (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
18.31
|
7.85
|
--
|
--
|
--
|
--
|
|||||
|
Current Assets
|
54.67
|
30.65
|
--
|
--
|
--
|
--
|
|||||
|
Total Assets
|
73.31
|
38.70
|
--
|
--
|
--
|
--
|
|||||
|
Total Debt*
|
39.99
|
15.01
|
--
|
--
|
--
|
--
|
|||||
|
Net Current Assets
|
35.48
|
17.39
|
--
|
--
|
--
|
--
|
|||||
|
Contingent Liabilities
|
--
|
--
|
--
|
--
|
--
|
--
|
Cashflow (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-6.03
|
-4.57
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
-2.31
|
0.05
|
--
|
--
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
8.43
|
4.52
|
--
|
--
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
0.09
|
0.00
|
--
|
--
|
--
|
--
|
Financials Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
12.83
|
10.57
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS (₹)
|
14.22
|
11.67
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value (₹)
|
28.88
|
16.05
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
-6.57
|
-4.98
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share (₹)
|
-12.52
|
-4.88
|
--
|
--
|
--
|
--
|
Profitability Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
39.14
|
48.73
|
--
|
--
|
--
|
--
|
|||||
|
ROE (%)
|
57.64
|
65.87
|
--
|
--
|
--
|
--
|
|||||
|
ROA (%)
|
21.33
|
25.20
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
43.66
|
37.82
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
27.57
|
25.32
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
30.29
|
27.95
|
--
|
--
|
--
|
--
|
Growth Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
12.45
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
29.82
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
22.50
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EPS Growth (%)
|
21.40
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
79.96
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
2.45
|
1.56
|
--
|
--
|
--
|
--
|
|||||
|
Close Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.51
|
1.02
|
--
|
--
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
0.22
|
0.21
|
--
|
--
|
--
|
--
|
|||||
|
Current Ratio
|
2.85
|
2.31
|
--
|
--
|
--
|
--
|
|||||
|
Quick Ratio
|
0.95
|
0.94
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
7.29
|
10.71
|
--
|
--
|
--
|
--
|
Operating Efficiency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.19
|
10.70
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
0.77
|
1.00
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
63.33
|
39.05
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
230.85
|
172.77
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
181.09
|
159.82
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
113.10
|
52.00
|
--
|
--
|
--
|
--
|